A role for inflammation in the development of IPAH is supported by enhanced pulmonary expression of various cytokines and chemokines, such as fractalkine and their association with inflammatory cell infiltrates in severe PAH [24], [25]. The gene discussed is CX3CL1; the disease is pulmonary arterial hypertension.